United States · FDA National Drug Code directory
Mirtazapine
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 57664-500_f5e842da-4922-4f1d-b2e0-a4c0be71e2a6
- Product NDC
- 57664-500
- Form
- TABLET
- Composition / generic term
- Mirtazapine
- Labeler
- Sun Pharmaceutical Industries, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20040422
- Source listing expiry
- 20261231
Source-listed ingredients
- MIRTAZAPINE — 30 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1000 TABLET in 1 BOTTLE (57664-500-18) · 57664-500-18
- 30 TABLET in 1 BOTTLE (57664-500-83) · 57664-500-83
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →